FDA Regulations 24 March 2026 - 26 May 2026

This Tiny Medical-Device Stock Is Back Above $11. Its Next FDA Test Is the Whole Trade
····

This Tiny Medical-Device Stock Is Back Above $11. Its Next FDA Test Is the Whole Trade

enVVeno Medical Corp. shares were last available at $11.25 before regular Nasdaq trading on Wednesday, up 18 cents from the prior close, giving the Irvine, California-based medical-device developer a market value of about $7.4 million. It is a small stock, so a modest price move can carry more noise than signal. The timing matters. Nasdaq’s regular market runs from 9:30 a.m. to 4 p.m. Eastern, and U.S. equity markets had just come through Monday’s Memorial Day closure; Wednesday was set up as a normal trading day, not a holiday tape.
May 27, 2026
Senti Biosciences Stock Near $1: FDA Signal and Cash Test Put SNTI Back on Watch
····

Senti Biosciences Stock Near $1: FDA Signal and Cash Test Put SNTI Back on Watch

Senti Biosciences Holdings Inc. shares edged higher in U.S. premarket trading Tuesday, holding near the $1 line as Wall Street came back from the Memorial Day break and investors weighed a recent FDA update against the biotech’s funding needs. The Nasdaq-listed stock was quoted at $0.9961 at 04:08 EDT, after closing Friday at $0.9869, up 0.28%; it slipped about 2.3% last week despite an 11.3% rebound on Wednesday. The timing matters because Monday was not a normal trading pause. Nasdaq’s U.S. equity and options markets were closed on May 25 for Memorial Day, leaving Tuesday as the first regular session after Friday’s close.
May 26, 2026
60 Degrees Pharma Nears FDA Deadline in Thin Holiday Trading
····

60 Degrees Pharma Nears FDA Deadline in Thin Holiday Trading

60 Degrees Pharmaceuticals Inc. goes into Tuesday with shares at $1.48, unchanged during a quiet session as U.S. stock markets closed Monday for Memorial Day. Investors are watching for a possible update as an FDA notification deadline falls the same day. According to the Nasdaq holiday calendar, markets were closed May 25, with usual trading hours set for 9:30 a.m. to 4 p.m. ET on standard days. No Monday tape and thin trading could hit the next move in SXTP. The stock dipped 0.7% Friday with 49,620 shares trading. Still, SXTP climbed 6.5% over the week, moving from $1.39 last Friday to $1.48 at the May 22 close.
May 25, 2026
British American Tobacco’s Velo Push Hits FDA Delay as U.S. Nicotine Pouch Reviews Stall
···

British American Tobacco’s Velo Push Hits FDA Delay as U.S. Nicotine Pouch Reviews Stall

British American Tobacco’s attempt to ramp up Velo nicotine pouch sales in the U.S. has hit a snag with regulators. Reuters said Wednesday that the U.S. Food and Drug Administration still hasn’t signed off on multiple products under a fast-track process, which had been expected to wrap up decisions by end-2025. BAT’s applications remain in limbo. Timing is key for BAT right now. The company’s counting on its smoke-free lineup—nicotine pouches, vapes, heated-tobacco—to offset the drag from falling cigarette sales. Back in February, BAT flagged that 2026 results would probably arrive at the lower boundary of its medium-term growth targets, despite 2025 shaping up to hit the top end of its guidance.
April 1, 2026
ImmunityBio Stock Sinks 21% After FDA Warning on Anktiva Cancer Claims
···

ImmunityBio Stock Sinks 21% After FDA Warning on Anktiva Cancer Claims

ImmunityBio stock tumbled roughly 21% this day, dragged down after the U.S. Food and Drug Administration accused the company’s TV ad and podcast for Anktiva of making false or misleading claims that breach federal law. Shares hovered around $7.44 late morning, well below the day’s $9.10 open. That’s a tough spot. Back on March 9, ImmunityBio announced the FDA had accepted its resubmitted bid to expand Anktiva’s label to include papillary-only non-muscle invasive bladder cancer, a type still confined to the bladder lining. The agency’s warning this Tuesday noted it had already raised similar marketing concerns, first in 2025, and again in January.
March 24, 2026